Nate Bennett, MD

Medical Director, Preferred Headache Center in the south suburbs of Pittsburgh. Headache & Concussion Specialist. UCNS Certified.

[Nate Bennett, MD @n8bennett]

https://t.co/qqOcMWNkNf

[Nate Bennett, MD @n8bennett]

@Neuralgroover They incorrectly use study criteria & endpoints as standards of care. For instance, in the ubro trials, it was required that patients have 4 migraine dys/mth to assure they would quickly have several chances to take the med. Now >=4 migraine dys/mth is required for the PA. BS!

[Nick Rickles @NickRickles]

People online vs Reality

[Nate Bennett, MD @n8bennett]

The puzzle of migraine chronification https://t.co/RqkjZMvzdo

[Nate Bennett, MD @n8bennett]

@AsiaHeadache @stephanieJnahas Congrats!

[Nate Bennett, MD @n8bennett]

Wednesday's marijuana legalization vote was truly historic — here's why https://t.co/PQg8PIZnJV

[Nate Bennett, MD @n8bennett]

2019 World Brain Day Takes Aim at Migraine https://t.co/gp2T3gqF2l via @YahooFinance

[Nate Bennett, MD @n8bennett]

Headache Highlights: From Killer to Cure—Botulinum Toxin as Therapy Turns 30 on @Practical_Derm https://t.co/WIvsDzIhaw

[Nate Bennett, MD @n8bennett]

Even a little bit of soda is a lot not good https://t.co/yXxszxaZk1 via @thetakeout

[Nate Bennett, MD @n8bennett]

@joannakempner Remember, association does not prove causation. This book presumes it does.

[Nate Bennett, MD @n8bennett]

https://t.co/84QAzWF5dx

[Aaron J. Zynda, PhD @ajzynda]

Dr. Shane Miller with a first look at preliminary data from our study on #DHA following pediatric #concussion. Results show that it is feasible, safe, and may allow for shorter time to symptom-free state. Thanks to @BertVargas for organizing! @TxScottishRite

[Nate Bennett, MD @n8bennett]

https://t.co/7iUIznx9LH

[Nate Bennett, MD @n8bennett]

Daaaaaaaa..........Neck pain: is it part of a migraine attack or a trigger before a migraine attack? https://t.co/6KG4wwkoRe

[Migraine Again @MigraineAgain00]

BREAKING NEWS: a second anti-CGRP treatment for Migraine prevention has been approved by the FDA. AJOVY should be available within 2 weeks. More: https://t.co/tR51XKOLpU

[The Headache Review @HeadacheReview]

"Excitingly, the #CGRP receptor is not just a villain, but can also [have] beneficial outcomes. ... there is accumulating evidence that activation of the receptor could be used to treat inflammatory bowel disease, or resistant hypertension." #migraine

https://t.co/MDHfQqSvcm

[Nate Bennett, MD @n8bennett]

Common painkiller has serious heart risks, study finds...oh no!
https://t.co/vos4F5KLsG

[Matthew Robbins, MD @mrobbinsmd]

Love seeing meaningful & clinically relevant #headache research 1st authored by #neurology residents. Congrats to @MayoClinicNeuro resident Levi Howard who also presented this as a platform at #AHS18SF.
@schwedtt @ahsheadache @HeadacheJournal

[Matthew Robbins, MD @mrobbinsmd]

An MRI is a great tool.
Taking a good history is an even better one.

[Nate Bennett, MD @n8bennett]

https://t.co/uoSyid356U